Please ensure Javascript is enabled for purposes of website accessibility

GLP-1 drugs

Mar 23, 2026

Eli Lilly selects Lehigh Valley for $3.5 billion life sciences plant in 2026

Eli Lilly announced a $3.5 billion manufacturing plant in Lehigh Valley, Pennsylvania, creating 850 jobs and marking the largest life sciences project in state history.

Jan 12, 2026

Lehigh Valley Business leaders head cautiously into 2026

Lehigh Valley leaders expect moderate economic growth in 2026, with office leasing rebounding, health care expanding and businesses watching costs and uncertainty.

Dec 16, 2025

LVBCHC: 2025 saw rising health insurance costs and new treatment options

Health care costs surged in 2025, with family coverage nearing $27,000 as employers weigh coverage for GLP-1 drugs, gene therapies and rising employee premiums.

Daniel Kuzmanovich of the Advisory Board, updates attendees at the Lehigh Valley Business Coalition's 45th Annual Conference on the State of the Healthcare Industry. PHOTO/LVBCH
May 20, 2025

Health care leaders tackle obesity, energy, Medicaid cuts

Lehigh Valley health experts discuss obesity, energy management, Medicaid changes, and GLP-1 drug trends at LVBCH’s 45th annual conference.